tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BrainStorm reports new survival data from EAP for NurOwn
PremiumThe FlyBrainStorm reports new survival data from EAP for NurOwn
1M ago
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
Premium
Ratings
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
2M ago
BrainStorm signs LOI with Minaris to manufacture NurOwn
Premium
The Fly
BrainStorm signs LOI with Minaris to manufacture NurOwn
2M ago
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
PremiumCompany AnnouncementsBrainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
2M ago
One new option listing and nine option delistings on May 19th
Premium
The Fly
One new option listing and nine option delistings on May 19th
2M ago
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
Premium
The Fly
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
2M ago
BrainStorm granted compliance extension from Nasdaq
PremiumThe FlyBrainStorm granted compliance extension from Nasdaq
4M ago
BrainStorm receives Notice of Allowance for patent on exosome technology
Premium
The Fly
BrainStorm receives Notice of Allowance for patent on exosome technology
8M ago
BrainStorm enters MOU with Pluri to support NurOwn trial
Premium
The Fly
BrainStorm enters MOU with Pluri to support NurOwn trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100